Journal
PIGMENT CELL RESEARCH
Volume 20, Issue 4, Pages 271-278Publisher
WILEY
DOI: 10.1111/j.1600-0749.2007.00384.x
Keywords
vitiligo; autoimmune disease; autoimmunity; genetics; gene mapping
Categories
Funding
- NIAID NIH HHS [AI46374] Funding Source: Medline
- NIAMS NIH HHS [AR45584] Funding Source: Medline
Ask authors/readers for more resources
Vitiligo is an acquired disorder in which patches of depigmented skin and often overlying hair, and mucous membranes, are the result of progressive autoimmune loss of melanocytes from the involved areas. Considered the most common pigmentary disorder, vitiligo involves complex interaction of environmental and genetic factors that ultimately contribute to melanocyte destruction, resulting in the characteristic depigmented lesions. In the past few years, studies of the genetic epidemiology of vitiligo have led to the recognition that generalized vitiligo is part of a broader autoimmune disease diathesis. Attempts to identify genes involved in susceptibility to generalized vitiligo have involved gene expression studies, genetic association studies of candidate genes, and genome-wide linkage analyses to discover new genes. These studies have begun to yield results that shed light on the mechanisms of vitiligo pathogenesis. It is anticipated that the discovery of biological pathways of vitilligo pathogenesis will provide novel targets for future approaches to the treatment and prevention of vitiligo and its associated autoimmune diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available